Boehringer Ingelheim’s investigational tyrosine kinase inhibitor BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis.
The National Organization for Rare Disorders released a report documenting flexibility in the Food and Drug Administration review of potential treatments for patients with rare diseases.
New research shows how metal surfaces that lack mirror symmetry could provide a novel approach towards manufacturing pharmaceuticals.
TxCell SA announced final positive results of a Phase 1/2 study in Crohn’s disease (CATS-1) with OvaSave.
Prosensa received an innovation credit of up to $6 million from AgentschapNL to support further development of a series of preclinical compounds for the treatment of myotonic dystrophy type 1.
A potential leukemia therapy targets only cancer cells, while leaving healthy cells alone.
Promega Corporation announced that it has launched GoTaq Long PCR Master Mix, an optimized enzyme mixture for improved long-range PCR; the kit enhances PCR yield, sensitivity, and specificity.
Thermo Fisher Scientific Inc. announced its µDrop Plate for the quick and easy measurement of samples down to 2 µL. The µDrop Plate provides a straightforward way of analyzing up to 16 microliter-scale samples simultaneously.
EMD Serono, Inc. and Fast Forward announced a commitment of up to $3 million in 2012 to support innovative early-stage projects directed towards the development of therapies to prevent, treat, or reverse nervous system damage in multiple sclerosis.
An innovative delivery method for human immunodeficiency virus (HIV) medications has been developed through use of a transdermal patch, the first of its kind to treat HIV.
S*BIO Pte Ltd announced plans to initiate a global Phase 3 clinical program of its JAK2 inhibitor pacritinib, to further demonstrate its activity and tolerability for the treatment of myelofibrosis.
The U.S. Food and Drug Administration approved Onfi tablets for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older.
People carrying extra pounds may need extra protection from influenza. New research shows that obesity may make annual flu shots less effective.
Pharmaceutical and biotech equipment company Merck said its net income rose 7.5% to $315 million in the third quarter as sales increased for key drugs.
Drugmaker Eli Lilly and Co. is withdrawing the severe sepsis treatment Xigris from all markets because a recently concluded study showed that it is no longer effective.